Isabela Dolci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabela Dolci has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Andre Schutzer Godoy
University of São Paulo
2 shared publications - Glaucius Oliva
Sao Carlos Institute of Physics, University of Sao Paulo, Av. Joao Dagnone, Sao Carlos, Brazil
2 shared publications Rafaela Sachetto Fernandes
Sao Carlos Institute of Physics, University of Sao Paulo, Av. Joao Dagnone, Sao Carlos, Brazil
2 shared publicationsAlpha A. Lee
PostEra Inc, Cambridge, USA
1 shared publicationAnnette von Delft
Centre for Medicines Discovery, University of Oxford, NDM research Building, Roosevelt Dr, Headington, Oxford, UK
1 shared publicationAnu V. Chandran
Diamond Light Source Ltd, Harwell Science and Innovation Campus, Didcot, UK
1 shared publication
Latest Publications
- Open Access
- 8 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors
The Zika viral protease NS2B-NS3 is essential for the cleavage of viral polyprotein precursor into individual structural and non-structural (NS) proteins and is therefore an attractive drug target. Generation of a robust crystal system of co-expressed NS2B-NS3 protease has enabled us to perform a crystallographic fragment screening campaign with 1076 fragments. 46 fragments with diverse scaffolds are identified to bind in the active site of the protease, with another 6 fragments observed in a potential allosteric site. To identify binding sites that are intolerant to mutation and thus suppress the outgrowth of viruses resistant to inhibitors developed from bound fragments, we perform deep mutational scanning of the NS2B-NS3 protease. Merging fragment hits yields an extensive set of ‘mergers’, defined as synthetically accessible compounds that recapitulate constellations of observed fragment-protein interactions. In addition, the highly sociable fragment hits enable rapid exploration of chemical space via algorithmic calculation and thus yield diverse possible starting points. In this work, we maximally explore the binding opportunities to NS2B-NS3 protease, facilitating its resistance-resilient antiviral development.
- 8 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessCombined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors
The Zika viral protease NS2B-NS3 is essential for the cleavage of viral polyprotein precursor into individual structural and non-structural (NS) proteins and is therefore an attractive drug target. Generation of a robust crystal system of co-expressed NS2B-NS3 protease has enabled us to perform a crystallographic fragment screening campaign with 1076 fragments. 46 fragments with diverse scaffolds are identified to bind in the active site of the protease, with another 6 fragments observed in a potential allosteric site. To identify binding sites that are intolerant to mutation and thus suppress the outgrowth of viruses resistant to inhibitors developed from bound fragments, we perform deep mutational scanning of the NS2B-NS3 protease. Merging fragment hits yields an extensive set of ‘mergers’, defined as synthetically accessible compounds that recapitulate constellations of observed fragment-protein interactions. In addition, the highly sociable fragment hits enable rapid exploration of chemical space via algorithmic calculation and thus yield diverse possible starting points. In this work, we maximally explore the binding opportunities to NS2B-NS3 protease, facilitating its resistance-resilient antiviral development.
- Top Cited PapersOpen Access
- 10 February 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , 103004
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
- 10 February 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , 103004
Top Cited PapersOpen AccessStructural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease